[Carcinoma of the esophagus: risk factors of morbimortality following esophagectomy]. / Carcinoma de esófago: factores de riesgo en la morbimortalidad tras esofaguectomía.

OBJECTIVE: To identify which perioperative risk factors are associated to postoperative morbidity and mortality in patients with carcinoma of the esophagus. DESIGN: We analyzed 8 perioperative risk factors: age, preoperative hospital stay, intraoperative blood transfusions, tumor stage, histology, grade of tumor differentiation, prior respiratory disease, surgical treatment. PATIENTS: Forty-six patients with esophageal carcinoma who underwent surgical resection. RESULTS: 1) Morbidity: There was statistical significance between the increase in postoperative morbidity and age > 75 years (p < 0.001), advanced stage of disease (p < 0.001), preoperative hospital stay higher than 20 days (p < 0.05) and severe respiratory disease (p < 0.05). 2) Mortality: There was a statistically significant increase in postoperative mortality in patients with preoperative hospital stay higher than 20 days and in patients > 75 years. CONCLUSIONS: The incidence of postoperative morbidity and mortality in esophageal cancer varies according to age, prior respiratory disease, tumor stage and preoperative hospital stay.

[Determination of the tumor marker CA 72-4 in gastric carcinoma]. / Determinación del marcador tumoral CA 72-4 en el carcinoma gástrico.

In this study, the authors determined the sensitivity and specificity of the new tumor marker CA 72-4 in detecting adenocarcinoma of the stomach. CA 72-4 serum levels were investigated in 279 patients consisting of: 100 control subjects, 88 patients with benign gastrointestinal disease and 91 patients with gastrointestinal cancer (31 with gastric cancer). We used a cut-off of 5 U/ml. The specificity of CA 72-4 was 91% and the sensitivity was 68%. Highest levels of CA 72-4 were found in patients with more advanced tumor (stages III-IV) and four of 5 patients with stage I had elevated levels of this tumor marker. These findings suggest that the use of serum CA 72-4 measurements may be more useful than other tumor markers in the diagnosis, prognosis and detection of recurrence in patients with gastric cancer. Although CA 72-4 can be elevated in other gastrointestinal adenocarcinomas, it can be useful in alerting the clinician to the possible presence of an intraabdominal neoplasm.